7Zheng CH,Yang XF.Expossion of MMP-7 and Fas ligand:theirapotosis-inducing effect on gastric cancer cell[J].Chinese Journal of Cancer Research,2003,15(3):1952201.
8HilskaM,Roberts PJ,Collan YU,et al.Prognostic significance of matrix metallop roteinases-1,-2,-7 and-13 and tissue inhibitors of metalloproteinases-1,-2,-3 and-4 in colorectal cancer[J].Int J Cancer,2007,121(4):714.
9Sier CFM,Kubben FJGM,Ganesh S,et al.Tissue levels of matrix metalloproteinases MM-2 and MM P-9 are related to the overall survival of patients with gastric carcinoma[J].Br J Cancer,1996,74 (3):413-417.
10Sutinen M,Kainulainen T,Hurskainen T,et al.Expression of matrix metalloproteinases (MM P-1 and-2) and their inh ibito rs(TIMP-1,-2,and-3) in oral lichen planus,dysplasia,squamouscell carcinoma and lymph node metastasis[J].Br J Cancer,1998,77 (8):2239.
1Castro FV,McGinn OJ,Krishnan S,et al. 5T4 oncofetal antigen is expressed in high risk of relapse childhood pre-B acute lymphoblastic leukemia and is associated with a more invasive and chemotactic phenotype[J]. Leukemia, 2012,26 (7) : 1487-1498.
2Krawczuk-Rybak M, Ku z micz M, Mroczko B, et al. Plasma matrix metalloproteinases MMP-2 and MMP-9 and tissue inhibitors TIMP-1 and TIMP-2 in children treated for acute lymphoblastic leukemia [J]. Pol Merkur Lekarski,2010,29(169) :14-18.
